Skip to main content

Trinity College Dublin, The University of Dublin

Trinity Menu Trinity Search



You are here Pharmacology & Therapeutics > Our Research > Publications

Our Publications

Show: AllPeer ReviewedNon Peer Reviewed
6 publications from 2023

O'Callaghan J, Tilson L, Fogarty E, McCullagh L , Clinical expert opinion to inform Health Technology Assessments., Irish Medical Journal, 116, (8), 2023
Journal Article; Published; Peer Reviewed; Author Profile: MCCULLLM

Cassidy O, Harte M, Trela-Larsen L, Walsh C, White A, McCullagh L, Leahy J., A comparison of relative-efficacy estimate(s) derived from both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2023, pS1098-3015(23)03061-9
Journal Article; Published; Peer Reviewed; Author Profiles: MCCULLLM WALSHC ; DOI

Rosealeen Barrett, Michael Barry, Laura McCullagh, Health technology management: the experience of a managed access approach to the reimbursement of dupilumab in Ireland, Irish Journal of Medical Science (1971 -), 2023
Journal Article; Published; Peer Reviewed; Author Profile: MCCULLLM; DOI

Croke A, Cardwell K, Clyne B, Moriarty F, McCullagh L, Smith SM., The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review., BMC Prim Care, 24, (1), 2023, p41
Journal Article; Published; Peer Reviewed; Author Profiles: MCCULLLM SUSMITH ; DOI

Claire Gorry, Laura McCullagh, Helen O'Donnell, Sarah Barrett, Susanne Schmitz, Michael Barry, Kay Curtin, Eamon Beausang, Rupert Barry, Imelda Coyne, Neoadjuvant treatment for stage III and IV cutaneous melanoma, Cochrane Database of Systematic Reviews, 2023, (1), 2023
Journal Article; Published; Peer Reviewed; Author Profiles: MCCULLLM COYNEI ; DOI

Niamh Carey, Joy Leahy, Lea Trela-Larsen, Laura Mc Cullagh, Michael Barry, Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting, Journal of Market Access & Health Policy, 11, (1), 2023
Journal Article; Published; Peer Reviewed; Author Profile: MCCULLLM; DOI